Skip to main content
ENCell Co., Ltd. logo

ENCell Co., Ltd. — Investor Relations & Filings

Ticker · 456070 ISIN · KR7456070002 KO Manufacturing
Open in API
Filings indexed 90 across all filing types
Latest filing 2024-11-20 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 456070

About ENCell Co., Ltd.

http://www.encellinc.com/en/

ENCell Co., Ltd. is a biopharmaceutical company specializing in advanced cell and gene therapies (CGT). The company's primary focus is providing Contract Development and Manufacturing Organization (CDMO) services, supported by globally recognized GMP facilities. Its offerings include process development, manufacturing, and contract quality testing (CQT) for a diverse portfolio of advanced therapies, including MSC, CAR-T, CAR-NK, and iPSC-derived cell therapies. ENCell leverages proprietary technologies such as the ROCKET Platform for multi-product GMP production and a next-generation stem cell platform designed to enhance yield and efficacy. In addition to its CDMO business, the company develops its own therapeutic pipeline. This internal research and development focuses on next-generation stem cell treatments, cancer immunotherapy, and AAV-based gene therapies, with a program for Duchenne Muscular Dystrophy in development.

Recent filings

Filing Released Lang Actions
[기재정정]분기보고서 (2024.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for ENCell Co., Ltd. (이엔셀 주식회사) for the third quarter of the 7th fiscal year (ending September 30, 2024). It contains comprehensive financial statements, management discussion and analysis, and corporate governance information. It is a full financial report, not an announcement or a summary, and therefore fits the definition of an Interim/Quarterly Report. 9M 2024
2024-11-20 Korean
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for ENCell Co., Ltd. (이엔셀 주식회사) covering the period from January 1, 2024, to September 30, 2024. It contains detailed financial statements, management discussion, and business operations information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-11-14 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling and logistics of an upcoming Investor Relations (IR) presentation. It specifies the date, time, method (online pre-recorded broadcast), and purpose of the event. Since it is an announcement of an event rather than the presentation slides themselves, and it serves as a regulatory notification of corporate activity, it falls under the category of a general regulatory filing or announcement.
2024-11-14 Korean
임원ㆍ주요주주특정증권등거래계획철회보고서
Share Issue/Capital Change Classification · 100% confidence The document is a 'Report on Withdrawal of Trading Plan for Specific Securities by Executives/Major Shareholders' (임원ㆍ주요주주특정증권등거래계획철회보고서) filed with the Korean Financial Services Commission and the Korea Exchange. This document details the cancellation of a previously reported stock trading plan by a major shareholder (Won & Partners) due to market volatility. Since this involves the reporting of insider/major shareholder trading activities and plans, it falls under the category of Director's Dealing (DIRS), which covers transactions and trading plans by insiders and major shareholders.
2024-11-04 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under Article 147 of the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties, including specific transaction dates, methods (e.g., open market sales, stock option exercises), and updated shareholding percentages. This fits the definition of a Major Shareholding Notification (MRQ).
2024-10-24 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (often referred to as an 'Insider Trading Report' or 'Director's Dealing' report) where company executives or major shareholders disclose changes in their shareholdings. Based on the provided categories, this aligns with 'Director's Dealing' (DIRS).
2024-10-16 Korean

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.